Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (71-80 of 340) with videos related to

Pageof 34
Sort By:
Molecular Oncology|January 25, 2023
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine populationShai Rosenberg, Gil Ben Cohen, Shumei Kato, et al.
Cancer|January 12, 2008
Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysisRobert S Svatek, J Jack Lee, Claus G Roehrborn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisitedEric A Klein, Catherine M Tangen, Phyllis J Goodman, et al.
Nature Reviews. Cancer|December 13, 2005
Statins and cancer preventionMarie-France Demierre, Peter D R Higgins, Stephen B Gruber, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2016
Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think TankWorta McCaskill-Stevens, Deborah C Pearson, Barnett S Kramer, et al.
Urology|May 6, 2008
Does the level of prostate cancer risk affect cancer prevention with finasteride?Ian M Thompson, Catherine M Tangen, Howard L Parnes, et al.
Cancer Research|October 3, 2003
Frontiers in cancer prevention researchAnita L Sabichi, Marie-France Demierre, Ernest T Hawk, et al.
Oncogene|September 20, 2005
Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expressionShumei Song, Scott M Lippman, Yiyu Zou, et al.
Cancer Research|December 13, 2006
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent needRonald B Herberman, Homer L Pearce, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Nucleotide excision repair pathway genes and oral premalignant lesionsYunfei Wang, Margaret R Spitz, J Jack Lee, et al.
Pageof 34

Showing results (71-80 of 340) with videos related to

Sort By:
Pageof 34
Molecular Oncology|January 25, 2023
Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real-world precision-medicine populationShai Rosenberg, Gil Ben Cohen, Shumei Kato, et al.
Cancer|January 12, 2008
Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysisRobert S Svatek, J Jack Lee, Claus G Roehrborn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2005
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisitedEric A Klein, Catherine M Tangen, Phyllis J Goodman, et al.
Nature Reviews. Cancer|December 13, 2005
Statins and cancer preventionMarie-France Demierre, Peter D R Higgins, Stephen B Gruber, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2016
Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think TankWorta McCaskill-Stevens, Deborah C Pearson, Barnett S Kramer, et al.
Urology|May 6, 2008
Does the level of prostate cancer risk affect cancer prevention with finasteride?Ian M Thompson, Catherine M Tangen, Howard L Parnes, et al.
Cancer Research|October 3, 2003
Frontiers in cancer prevention researchAnita L Sabichi, Marie-France Demierre, Ernest T Hawk, et al.
Oncogene|September 20, 2005
Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expressionShumei Song, Scott M Lippman, Yiyu Zou, et al.
Cancer Research|December 13, 2006
Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent needRonald B Herberman, Homer L Pearce, Scott M Lippman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Nucleotide excision repair pathway genes and oral premalignant lesionsYunfei Wang, Margaret R Spitz, J Jack Lee, et al.
Pageof 34